Christine A. Haller
Department of Medicine and Clinical Pharmacy
University of California
San Francisco
California
USA
Name/email consistency: high
- Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory. Haller, C.A., Stone, J., Burke, V., Branch, J., Chen, K., Gross, S. J. Anal. Toxicol (2006)
- Seizures reported in association with use of dietary supplements. Haller, C.A., Meier, K.H., Olson, K.R. Clin. Toxicol. (Phila) (2005)
- Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Haller, C.A., Jacob, P., Benowitz, N.L. Clin. Pharmacol. Ther. (2005)
- Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Haller, C.A., Jacob, P., Benowitz, N.L. Clin. Pharmacol. Ther. (2004)
- Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. Haller, C.A., Duan, M., Benowitz, N.L., Jacob, P. J. Anal. Toxicol (2004)
- St John's wort, depression, and catecholamines. Haller, C.A. Clin. Pharmacol. Ther. (2004)
- Making a diagnosis of herbal-related toxic hepatitis. Haller, C.A., Dyer, J.E., Ko, R., Olson, K.R. West. J. Med. (2002)
- Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Haller, C.A., Jacob, P., Benowitz, N.L. Clin. Pharmacol. Ther. (2002)
- An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Haller, C.A., Anderson, I.B., Kim, S.Y., Blanc, P.D. Adverse. Drug. React. Toxicol. Rev (2002)
- We should always ask our patients about unconventional treatments. Haller, C.A. West. J. Med. (2001)